Jason A. Leverone, Chief Financial Officer at OnKure Therapeutics, Inc. (OKUR), sold 602 shares at $4.16 ($3K) on 2026-03-23, disclosed to the SEC on 2026-03-24.
Open-market sale of $3k OKUR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.16 | 301 | $1K | 50.0% |
| 2 | $4.16 | 301 | $1K | 50.0% |
| Total | $4.16 avg | 602 | $3K | 100% |
| Filing → |
| OKUR | SELL | 2025-12-23 | $897 | — | Filing → |
| OKUR | SELL | 2025-09-24 | $794 | — | Filing → |
| OKUR | SELL | 2025-06-25 | $721 | — | Filing → |